Pacira Pharmaceuticals Announces Timing for Third Quarter 2016 Financial Results Webcast and Conference Call
October 17 2016 - 4:00PM
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that
financial results for the company’s third quarter ended September
30, 2016 will be released before the market opens on Wednesday,
November 2, 2016. The Pacira management team will host a conference
call to discuss the company’s financial results and recent and
upcoming developments on Wednesday, November 2, 2016, at 9 a.m. ET.
The call can be accessed by dialing 1-877-845-0779 (domestic) or
1-720-545-0035 (international) ten minutes prior to the start of
the call and providing the Conference ID 12896365.
A replay of the call will be available approximately two hours
after the completion of the call and can be accessed by dialing
1-855-859-2056 (domestic) or 1-404-537-3406 (international) and
providing the Conference ID 12896365. The replay of the call will
be available for two weeks from the date of the live call.
The live, listen-only webcast of the conference call can also be
accessed by visiting the “Investors & Media” section of the
company’s website at investor.pacira.com. A replay of the webcast
will be archived on the Pacira website for two weeks following the
call.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s flagship product,
EXPAREL® (bupivacaine liposome injectable suspension), indicated
for single-dose infiltration into the surgical site to produce
postsurgical analgesia, was commercially launched in the United
States in April 2012. EXPAREL and two other products have
successfully utilized DepoFoam®, a unique and proprietary product
delivery technology that encapsulates drugs without altering their
molecular structure, and releases them over a desired period of
time. Additional information about Pacira is available at
www.pacira.com.
Investor Contact:
Pacira Pharmaceuticals, Inc.
Jessica Cho, (973) 254-3574
jessica.cho@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Apr 2023 to Apr 2024